Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
9.54M
-
Shares change
-
+596K
-
Total reported value, excl. options
-
$40.9M
-
Value change
-
+$2.59M
-
Number of buys
-
27
-
Number of sells
-
-18
-
Price
-
$4.29
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q3 2018
72 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q3 2018.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.54M shares
.
Largest 10 shareholders include BlackRock Inc. (1.91M shares), ICONIQ Capital, LLC (1.71M shares), Vanguard Group Inc (1.57M shares), Tieton Capital Management, LLC (1.08M shares), STATE STREET CORP (566K shares), NORTHERN TRUST CORP (406K shares), GEODE CAPITAL MANAGEMENT, LLC (329K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (268K shares), UBS Group AG (145K shares), and Bank of New York Mellon Corp (104K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.